Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Non-interventional, Epidemiologic Study of XLMTM and Clinical Expression in the Liver

NCT06581146 is registered in ClinicalTrials.gov with Astellas Gene Therapies as lead sponsor.

NCT NCT06581146
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06581146 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Non-interventional, Epidemiologic Study of XLMTM and Clinical Expression in the Liver
Lead sponsor
Astellas Gene Therapies
Phase
Observational
Overall status
Recruiting
Start date
May 19, 2025
Completion date
December 31, 2027
Enrollment
50 (estimated)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

x-linked myotubular myopathy